NCT00154414 Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00154401 Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE2
NCT00147836 Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients Status COMPLETED Phase NA
NCT00135473 Efficacy of Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP Trial) Status COMPLETED Phase PHASE3
NCT00134745 Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome Status COMPLETED Phase PHASE4
NCT00127296 Reliability of Dosing With NovoLog® Mix 70/30 FlexPen® Compared With Vial and Syringe Status COMPLETED Phase PHASE1
NCT00124293 Incidence/Magnitude-Haemorrhagic Progression-Cerebral Contusions and Identification (ID) of Safety Issues After Traumatic Brain Injury Status COMPLETED Phase N/A
NCT00123591 Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury Status COMPLETED Phase PHASE2
NCT00117780 Comparison of Insulin Detemir Given Once or Twice Daily in Type 1 Diabetes Status COMPLETED Phase PHASE4
NCT00115973 A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump Status COMPLETED Phase PHASE1
NCT00115479 KULeuven Intensive Insulin Therapy Study in Medical Intensive Care Patients Status COMPLETED Phase PHASE2
NCT00108849 Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms Status COMPLETED Phase PHASE3
NCT00108758 Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia Status COMPLETED Phase PHASE2
NCT00106366 Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00104455 Dose Response to Recombinant Factor VIIa When Administered for Bleed Status COMPLETED Phase PHASE1
NCT00104182 Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT00102817 Somatropin (Norditropin) in Insulin-like Growth Factor (IGF) Deficient Children Status COMPLETED Phase PHASE3